Side-by-side IPO readiness, funding history, and valuation comparison. Data sourced by TechStackIPO.
| Metric | Canva | Crossbow Therapeutics |
|---|---|---|
| Total funding | $770M | $450M |
| Latest round | Series F | Series E |
| Amount | $200M | $1.5B |
| Date | Sep 2021 | Jul 2026 |
| Valuation | $40B | Undisclosed |
| Lead investors | T. Rowe Price | Undisclosed |
Scores, valuations, and signals for Canva, Crossbow Therapeutics, and 370+ companies. 5-min read every Tuesday.
Canva is the world's leading design platform with 250M+ users — valued at $48B with $770M raised. Track IPO timeline, funding rounds, and readiness score.
| Industry | Design & Creative |
| Stage | Pre-IPO |
| IPO Status | Private |
| Valuation | $42B |
| Total Funding | $770M |
| Headquarters | Sydney, Australia |
Biotech company developing precision antibody therapies for cancer treatment
| Industry | Biotech / Oncology |
| Stage | series_e |
| IPO Status | Pre-IPO |
| Valuation | $1.8B |
| Total Funding | $450M |
| Headquarters | Cambridge, MA |
Complete funding history, cap table, S-1 analysis, and investor breakdown for any company. Instant PDF download.
Or buy any single company report for $19
Canva is valued at $42B. Crossbow Therapeutics is valued at $1.8B. Both figures are based on the most recent funding rounds tracked by TechStackIPO.
Canva reported 4000000000 revenue in 2025. Crossbow Therapeutics's revenue is not publicly disclosed. Revenue figures are sourced from TechStackIPO's company database and updated as new data becomes available.
Canva filed an S-1 in August 2026 and is actively in the IPO pipeline. Crossbow Therapeutics is currently pre-IPO. Track both companies on TechStackIPO for S-1 filings, roadshow announcements, and IPO date updates.
Canva has raised $770M. Crossbow Therapeutics has raised $450M.
Canva operates in Design & Creative, while Crossbow Therapeutics operates in Biotech / Oncology.
Canva is a Design & Creative company valued at $42B with $770M raised. Crossbow Therapeutics is a Biotech / Oncology company valued at $1.8B with $450M raised. See TechStackIPO's full side-by-side comparison for IPO readiness scores, funding timelines, and investor access options.
Accredited investors can access pre-IPO shares in Canva and Crossbow Therapeutics through secondary market platforms, pre-IPO funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace section tracks available access options for both companies. Pre-IPO investments carry higher risk and limited liquidity.